Category: Science
Expanding the Tool Box: New Melanoma Treatment Approaches Being Explored
29 July 2020 In Science, Treatment
Despite the tremendous progress made in melanoma treatments over the last 10 years, only about half of such patients respond favorably to current treatments. During the MRA’s Melanoma > Exchange Patient & Advocate Forum, MRA-funded investigators shared updates on emerging science and promising clinical trials.
For Melanoma Researcher Dr. Betina Yanez, It’s All About the Journey
By Cody R. Barnett, MRA Director of Communications | 27 July 2020 In Science
If you close your eyes and imagine what a melanoma researcher looks like, Dr. Betina Yanez is probably not what you imagine. That’s because Dr. Yanez, a health psychologist by training, isn’t your typical melanoma researcher. Instead of researching new treatment targets or experimental combination therapies, she focuses on patient experience and quality of life.
Basic Research: Understanding what Triggers Melanoma and its Spread to Identify New Treatment Targets
9 July 2020 In Science
Tremendous progress has been made in understanding the basic biology needed to trigger melanoma and fuel its growth and progression. Researchers continue to probe deeper, finding new molecular culprits that could lead to novel and more effective melanoma treatment strategies. Some of these new potential drug targets were revealed at MRA’s 2020 Scientific Retreat.
Melanoma Research Updates from 2020 AACR and ASCO Conferences
By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 29 June 2020 In News, Science, Treatment
MRA Chief Science Officer Marc Hurlbert shares exciting melanoma research highlights from ASCO and AACR - the two largest global cancer research conferences that take place annually.
A Personal Journey, A Virtual Platform
23 June 2020 In Melanoma Stories, Prevention, Science
Meet Shirin Bajaj, a third-year resident at NYU’s School of Medicine and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.
Maintaining Momentum in Melanoma Research
8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment
The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.
From Dermatology to Treatment: Second Opinions, Clinical Trials & becoming Your Own Best Advocate
By Cody R. Barnett, MRA Director of Communications | 29 May 2020 In Melanoma Stories, Science, Treatment
Through his journey with melanoma, Patrick has learned the importance of always being his own best advocate, getting second opinions, and considering clinical trials.
Lighting up Melanoma (One Cell at a Time)
18 May 2020 In Allies & Partnerships, Prevention, Science, Treatment
Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.
Putting Healthy Skin First - L’Oréal Active Cosmetics Division & MRA Strengthen Longstanding L’Oréal and MRA Partnership
By Cody R. Barnett, MRA Director of Communications | 1 May 2020 In Allies & Partnerships, News, Science
Some partnerships just make sense. For example, L’Oréal-owned SkinCeuticals, CeraVe and La Roche-Posay apart of the L’Oreal Active Cosmetics Division and MRA both share a mission and ethos for promoting healthy skin. It is no surprise that the two are longtime partners in the fight against melanoma. In fact, these brands and MRA have just announced an expanded partnership just in time for Melanoma Awareness Month.
MRA Announces $11 Million for 26 Grant Awards to Advance Melanoma Research
By Cody R. Barnett, MRA Director of Communications | 30 April 2020 In News, Science
With the world’s attention focused on the response to COVID-19, the Melanoma Research Alliance (MRA) knows that long after this pandemic has ended, melanoma research will still be urgently needed. To this end, and in recognition of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, is proud to announce funding for 26 research awards totaling $10.9 million.